| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.29 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.18 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |